Neuralink earns $280M funding round
Neuralink earned a $280 million series D funding round, the company said in an Aug. 7 tweet.
Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neuralink earned a $280 million series D funding round, the company said in an Aug. 7 tweet.
The first oral pill in the United States specifically for postpartum depression, a serious mental illness, has been approved by the US Food and Drug Administration (FDA).
The Food and Drug Administration on Friday granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy.
The Food and Drug Administration on Friday granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy.
Tribe Clinical Research launched two clinical trials focusing on weight loss data collection